Key points are not available for this paper at this time.
Cost-effectiveness of influenza vaccination varied by age and risk status and was less than 95, 000/QALY for all subgroups, except for non-high-risk working-age adults. Results were sensitive to the probability of influenza illness and vaccination was more favorable under certain scenarios. Vaccination for higher risk subgroups resulted in ICERs below 100, 000/QALY even at low levels of vaccine effectiveness or circulating virus.
DeLuca et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: